Lumos Pharma logo
Lumos Pharma LUMO
$ 4.34 0.0%

Квартальный отчет 2024-Q3
добавлен 07.11.2024

report update icon

Lumos Pharma Мультипликаторы 2011-2024 | LUMO

Мультипликаторы по годам Lumos Pharma

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-0.7 -1.0 -2.7 -25.2 -0.3 -0.1 -0.4 -0.4 -1.9 9.9 -29.8 -10.3 -2.3

P/S

12.0 20.1 362.4 849.0 14.4 0.5 1.0 1.1 1.1 5.9 850.3 142.9 22.6

EPS

-4.2 -3.7 -3.6 -0.9 -1.1 -1.4 -2.3 -2.9 -1.4 3.5 -1.2 -1.1 -3.0

EV (Enterprise Value)

2.85 млн -12.7 млн -129 тыс. 56.4 млн -75.6 млн -99 млн -100 млн -48.3 млн -95.5 млн 863 млн 880 млн 232 млн 14.4 млн

EBITDA per Share

-4.49 -3.82 -3.74 -3.1 -5.24 -14.8 -20.5 -27.5 -10.1 4.26 -1.2 -1.08 -2.87

EV/EBITDA

0.0 -1.7 -0.2 1.9 1.8 1.0 3.7 8.6 -30.7 -10.7 -2.5

PEG

0.06 0.04 0.1 -8.67 -0.02 -0.0 -0.02 0.0 0.0 0.02 3.01 -0.17 -0.03

P/B

0.9 0.5 0.9 1.2 0.2 0.1 0.2 0.3 0.4 5.0 15.9 13.4 1.1

P/CF

-0.8 -1.2 -2.8 -6.2 -0.4 -0.2 -0.6 -0.6 -2.8 9.5 -34.2 -11.1 -3.2

ROE %

-124.64 -52.13 -34.20 -4.86 -54.50 -46.55 -47.47 -65.77 -20.63 50.48 -53.46 -130.09 -49.19

ROA %

-83.75 -42.97 -30.34 -4.39 -777.94 -40.93 -39.82 -48.73 -18.48 43.21 -44.19 -79.24 -37.39

ROCE %

-134.09 -53.77 -32.93 -22.56 -1058.74 -51.14 -45.93 -66.32 -16.50 55.19 -46.70 -87.74 -47.89

Current Ratio

3.0 5.7 8.8 10.4 4.0 14.4 8.0 4.4 14.0 9.2 16.5 8.0 4.0

DSO

- - - - 13.6 23.4 133.9 311.3 28.7 7.9 443.5 42.4 0.2

DIO

- - - - - - - - - - - - -

DPO

- - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - -

Все данные представлены в валюте USD

Мультипликаторы поквартально Lumos Pharma

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.9 -0.93 -1.29 - -1.04 -1.09 -0.89 - -0.86 -0.94 -0.92 - -0.9 -0.99 -1.04 - 0.21 -0.65 -0.14 -0.22 -2.56 -0.27 -0.27 -0.28 -0.2 -0.47 -0.49 -0.37 -0.69 -0.57 -0.72 -0.46 -0.54 -1.12 -0.82 -0.75 -0.55 -0.49 0.4 4.29 -0.2 -0.33 -0.33 -0.31 -0.32 -0.28 -0.33 -0.3 -0.28 -0.31 -0.23 -0.44 -1.09 -1.2 -1.07

EBITDA per Share

- - -1.34 - - - -0.97 - -0.9 -0.95 -0.92 - -0.87 -0.97 -1.02 - -0.82 -0.79 -2.38 -7.38 -1.99 -1.92 -1.59 -0.29 -0.38 -0.46 -0.49 -0.38 -0.66 -0.55 -0.71 -0.48 -0.52 -1.15 -0.86 -0.51 -0.51 -0.53 0.47 5.33 -0.44 -0.31 -0.33 -0.3 -0.29 -0.26 -0.33 -0.3 -0.25 -0.29 -0.23 -0.28 -0.94 -1.11 -1.02

ROE %

-308.70 -180.13 -127.10 -57.83 -68.54 -55.86 -45.93 -30.67 -38.62 -35.87 -33.92 -24.45 -22.94 -13.47 -9.48 -2.79 11.12 14.10 23.01 26.26 34.87 23.96 4.60 -14.84 -46.40 -53.58 -49.58 -47.47 -48.88 -47.27 -61.25 -60.87 -61.46 -57.58 -39.76 -20.63 51.33 56.62 59.32 49.07 -25.67 -36.75 -44.39 -53.46 -74.91 -93.62 -116.68 -130.09 -110.64 -72.42 -49.17 -32.76 5.58 -11.95 -10.60

ROA %

-132.69 -107.31 -87.79 -44.75 -53.91 -45.68 -39.02 -26.62 -33.65 -31.53 -29.94 -21.81 -20.44 -12.04 -8.60 -2.52 -152.19 -201.86 -244.20 -282.56 -140.95 -98.31 -65.04 -40.93 -40.43 -46.19 -42.23 -39.82 -39.97 -37.45 -46.73 -48.73 -50.87 -49.26 -37.17 -18.48 43.30 48.16 50.75 41.75 -21.55 -30.64 -36.83 -44.19 -54.26 -62.63 -74.04 -79.24 -69.78 -58.14 -45.78 -37.39 -8.24 -9.08 -8.06

ROCE %

- - -13.69 -27.37 -37.61 -34.17 -44.00 -28.86 -36.33 -33.55 -31.78 -23.01 -28.85 -27.23 -24.78 -15.70 -1.04 9.35 19.33 27.20 39.92 23.05 4.14 -14.79 -51.03 -51.89 -47.89 -45.93 -47.29 -46.31 -61.00 -61.42 -58.49 -54.00 -36.59 -16.50 63.06 64.44 67.98 57.31 -26.84 -32.69 -39.01 -46.70 -58.57 -68.46 -81.63 -87.74 -79.39 -51.69 -39.57 -31.72 5.64 -11.65 -10.32

Current Ratio

1.4 1.9 2.6 3.0 3.9 4.4 5.7 5.7 6.9 7.8 8.2 8.8 8.6 8.7 10.8 10.3 10.3 10.3 10.3 3.8 3.8 3.8 3.8 8.3 8.3 8.3 8.3 6.2 6.2 6.2 6.2 3.9 3.9 3.9 3.9 9.6 9.6 9.6 9.6 6.7 6.7 6.9 6.9 5.8 5.8 5.8 5.8 2.6 2.6 2.6 2.6 4.2 4.2 4.2 4.2

DSO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 42.4 564.7 141.9 54.0 223.7 96.5 64.2 34.6 66.0 10.6 2.0 121.1 1599.5 689.0 412.2 457.3 522.3 230.2 - - - - - - - -

DIO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Операционный цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 42.4 564.7 141.9 54.0 223.7 96.5 64.2 34.6 66.0 10.6 2.0 121.1 1599.5 689.0 412.2 457.3 522.3 230.2 - - - - - - - -

Финансовый цикл

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - 42.4 564.7 141.9 54.0 223.7 96.5 64.2 34.6 66.0 10.6 2.0 121.1 1599.5 689.0 412.2 457.3 522.3 230.2 - - - - - - - -

Все данные представлены в валюте USD